Login
$KURA
$7.15 +$0.06 (0.85%) After hours

$KURA SEC Filings

Filed On Filing
16 Nov 2026 Form 4: Wilson Troy Edward, Director

Bought 98,881 shares ($754K) · Bought 101,119 shares ($750K)

16 Nov 2026 144
16 Nov 2026 144
16 Nov 2026 144
16 Nov 2026 144
16 Nov 2026 144
16 Nov 2026 SCHEDULE 13G/A
10 Nov 2026 S-3ASR
10 Nov 2026 10-Q
10 Nov 2026 8-K: Results of Operations and Financial Condition

– KOMZIFTI®(ziftomenib) net product revenue grew 53% sequentially to $13.9 million; new patient starts increased 30% and total prescriptions grew 65% –

27 Oct 2026 SCHEDULE 13G/A
29 Sep 2026 Form 4: Bair Teresa Brophy, Chief Legal Officer

Sold 8,442 shares ($88.6K)

29 Sep 2026 Form 4: Ford Kathleen, Chief Operating Officer

Sold 6,906 shares ($72.5K) · Sold 3,668 shares ($39.4K)

29 Sep 2026 Form 4: Leoni Mollie, Chief Medical Officer

Sold 12,448 shares ($131K) · Sold 28,802 shares ($310K)

29 Sep 2026 Form 4: Doyle Thomas James, SVP, Finance & Accounting

Sold 4,607 shares ($48.4K)

29 Sep 2026 Form 4: Powl Brian T., Chief Commercial Officer

Sold 17,020 shares ($179K) · Sold 15,430 shares ($166K)

29 Sep 2026 144
29 Sep 2026 144
29 Sep 2026 144
28 Sep 2026 144

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support